Literature DB >> 26748217

Avoidance of Fiber Is Associated With Greater Risk of Crohn's Disease Flare in a 6-Month Period.

Carol S Brotherton1, Christopher A Martin2, Millie D Long2, Michael D Kappelman3, Robert S Sandler2.   

Abstract

BACKGROUND & AIMS: Chronic inflammatory bowel diseases (IBDs) have been associated with an abnormal mucosal response to the gastrointestinal microbiota. Although dietary fiber affects the gastrointestinal microbiota, there is limited information on the role of fiber on IBD activity. We investigated factors associated with fiber consumption and whether it was associated with flares in patients with IBD.
METHODS: We collected a completed 26-item dietary survey from 1619 participants in the Crohn's and Colitis Foundation of America Partners Internet cohort (Crohn's disease, 1130; ulcerative colitis/indeterminate colitis, 489). Eligible individuals were in remission based on disease activity index at baseline and completed a follow-up survey 6 months later. Fiber and whole grain consumption were categorized into quartiles and deciles. Disease flare at 6 months was defined as a disease activity index score exceeding remission cutoff values, and/or an IBD-related surgical procedure or hospitalization since baseline.
RESULTS: Participants with longer duration of disease, past history of surgery, and past IBD hospitalization ate less fiber. The risks for disease flare differed by disease type. Compared with those in the lowest quartile of fiber consumption, participants with Crohn's disease in the highest quartile were less likely to have a flare (adjusted odds ratios [OR], 0.58; 95% confidence interval [CI], 0.37-0.90). Participants with Crohn's disease who reported that they did not avoid high-fiber foods were ∼40% less likely to have a disease flare than those who avoided high-fiber foods (adjusted OR, 0.59; 95% CI, 0.43-0.81). There was no association between fiber intake and flares in patients with ulcerative colitis (adjusted OR, 1.82; 95% CI, 0.92-3.60).
CONCLUSIONS: Intake of dietary fiber is associated with reduced disease flares in patients with Crohn's disease, but not UC. Recommendations to limit dietary fiber should be re-evaluated.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diet; Dysbiosis; Inflammatory Bowel Disease; Microbiota; Short-Chain Fatty Acids

Mesh:

Year:  2015        PMID: 26748217      PMCID: PMC4930425          DOI: 10.1016/j.cgh.2015.12.029

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  27 in total

1.  Germinated barley foodstuff feeding. A novel neutraceutical therapeutic strategy for ulcerative colitis.

Authors:  O Kanauchi; T Iwanaga; K Mitsuyama
Journal:  Digestion       Date:  2001       Impact factor: 3.216

2.  Clinical trial: the microbiological and immunological effects of synbiotic consumption - a randomized double-blind placebo-controlled study in active Crohn's disease.

Authors:  H Steed; G T Macfarlane; K L Blackett; B Bahrami; N Reynolds; S V Walsh; J H Cummings; S Macfarlane
Journal:  Aliment Pharmacol Ther       Date:  2010-10       Impact factor: 8.171

3.  Effects of an oral supplementation of germinated barley foodstuff on serum tumour necrosis factor-alpha, interleukin-6 and -8 in patients with ulcerative colitis.

Authors:  Zeinab Faghfoori; Lida Navai; Rahebeh Shakerhosseini; Mohammad Hossein Somi; Zeinab Nikniaz; Mohammad Fahmideh Norouzi
Journal:  Ann Clin Biochem       Date:  2011-03-02       Impact factor: 2.057

4.  Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease.

Authors:  Jane L Benjamin; Charlotte R H Hedin; Andreas Koutsoumpas; Siew C Ng; Neil E McCarthy; Ailsa L Hart; Michael A Kamm; Jeremy D Sanderson; Stella C Knight; Alastair Forbes; Andrew J Stagg; Kevin Whelan; James O Lindsay
Journal:  Gut       Date:  2011-01-24       Impact factor: 23.059

5.  Trends in dietary fiber intake in the United States, 1999-2008.

Authors:  Dana E King; Arch G Mainous; Carol A Lambourne
Journal:  J Acad Nutr Diet       Date:  2012-04-25       Impact factor: 4.910

6.  Fiber as protective against gastrointestinal diseases.

Authors:  D Burkitt
Journal:  Am J Gastroenterol       Date:  1984-04       Impact factor: 10.864

7.  Performance of the Automated Self-Administered 24-hour Recall relative to a measure of true intakes and to an interviewer-administered 24-h recall.

Authors:  Sharon I Kirkpatrick; Amy F Subar; Deirdre Douglass; Thea P Zimmerman; Frances E Thompson; Lisa L Kahle; Stephanie M George; Kevin W Dodd; Nancy Potischman
Journal:  Am J Clin Nutr       Date:  2014-04-30       Impact factor: 7.045

8.  The effects of an oral supplement enriched with fish oil, prebiotics, and antioxidants on nutrition status in Crohn's disease patients.

Authors:  Dawn M Wiese; Bret A Lashner; Edith Lerner; Stephen J DeMichele; Douglas L Seidner
Journal:  Nutr Clin Pract       Date:  2011-08       Impact factor: 3.080

9.  Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study.

Authors:  Claes Hallert; Inger Björck; Margareta Nyman; Anneli Pousette; Christer Grännö; Hans Svensson
Journal:  Inflamm Bowel Dis       Date:  2003-03       Impact factor: 5.325

10.  Dietary fiber information for individuals with Crohn disease: reports of gastrointestinal effects.

Authors:  Carol S Brotherton; Ann Gill Taylor
Journal:  Gastroenterol Nurs       Date:  2013 Sep-Oct       Impact factor: 0.978

View more
  36 in total

Review 1.  Non-pharmacological therapies for inflammatory bowel disease: Recommendations for self-care and physician guidance.

Authors:  Whitney Duff; Natasha Haskey; Gillian Potter; Jane Alcorn; Paulette Hunter; Sharyle Fowler
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

Review 2.  Dietary fibre in gastrointestinal health and disease.

Authors:  Samantha K Gill; Megan Rossi; Balazs Bajka; Kevin Whelan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-11-18       Impact factor: 46.802

3.  Interactions Between Diet and the Intestinal Microbiota Alter Intestinal Permeability and Colitis Severity in Mice.

Authors:  Sean R Llewellyn; Graham J Britton; Eduardo J Contijoch; Olivia H Vennaro; Arthur Mortha; Jean-Frederic Colombel; Ari Grinspan; Jose C Clemente; Miriam Merad; Jeremiah J Faith
Journal:  Gastroenterology       Date:  2017-11-23       Impact factor: 22.682

4.  A Novel Patient-Reported Outcome-Based Evaluation (PROBE) of Quality of Life in Patients With Inflammatory Bowel Disease.

Authors:  Edward L Barnes; Michael D Kappelman; Millie D Long; Donna M Evon; Christopher F Martin; Robert S Sandler
Journal:  Am J Gastroenterol       Date:  2019-04       Impact factor: 10.864

Review 5.  Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.

Authors:  R Balfour Sartor; Gary D Wu
Journal:  Gastroenterology       Date:  2016-10-18       Impact factor: 22.682

Review 6.  Modifiable Environmental Factors in Inflammatory Bowel Disease.

Authors:  Kristin E Burke; Christine Boumitri; Ashwin N Ananthakrishnan
Journal:  Curr Gastroenterol Rep       Date:  2017-05

7.  Implementing Dietary Modifications and Assessing Nutritional Adequacy of Diets for Inflammatory Bowel Disease.

Authors:  Nicolaus Nazarenkov; Kristina Seeger; Lori Beeken; Ashwin N Ananthakrishnan; Hamed Khalili; James D Lewis; Gauree Gupta Konijeti
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-03

8.  Digital Cohorts Within the Social Mediome: An Approach to Circumvent Conventional Research Challenges?

Authors:  Anand Kulanthaivel; Rachel Fogel; Josette Jones; Craig Lammert
Journal:  Clin Gastroenterol Hepatol       Date:  2017-05       Impact factor: 11.382

Review 9.  Role of Diet in the Development and Management of Crohn's Disease.

Authors:  Donald Goens; Dejan Micic
Journal:  Curr Gastroenterol Rep       Date:  2020-03-17

10.  High Patient Activation Is Associated With Remission in Patients With Inflammatory Bowel Disease.

Authors:  Edward L Barnes; Millie D Long; Michael D Kappelman; Christopher F Martin; Robert S Sandler
Journal:  Inflamm Bowel Dis       Date:  2019-06-18       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.